Summary of opinion: Tevimbra, 22/05/2025 Positive

Start of Union reviews adopted during the CHMP meeting of 19-22 May 2025

Human medicines European public assessment report (EPAR): Revestive, teduglutide, Date of authorisation: 30/08/2012, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR): Nerlynx, neratinib, Date of authorisation: 31/08/2018, Revision: 14, Status: Authorised

Training session for patients, consumers and healthcare professionals involved in medicine regulatory activities July 2025, European Medicines Agency, Amsterdam, the Netherlands, from 2 July 2025, 09:30 (CEST) to 2 July 2025, 16:15 (CEST)

Human medicines European public assessment report (EPAR): Uptravi, selexipag, Date of authorisation: 12/05/2016, Revision: 18, Status: Authorised

HMPC meeting report on European Union herbal monographs, guidelines and other activities - 05-07 May 2025

Orientation guide for patient representatives and healthcare professionals - EMA building

Orientation guide for delegates - EMA building

Agenda - EMA’s 30th anniversary scientific conference